BASSO CAPITAL MANAGEMENT, L.P. - THERAVANCE INC ownership

THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 2 filers reported holding THERAVANCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BASSO CAPITAL MANAGEMENT, L.P. ownership history of THERAVANCE INC
ValueSharesWeighting
Q2 2018$4,186,000
-17.8%
4,342,000
-8.8%
0.80%
-15.3%
Q1 2018$5,092,000
+3.9%
4,759,000
-4.2%
0.94%
+17.6%
Q4 2017$4,903,000
-22.2%
4,969,000
-23.3%
0.80%
+2.4%
Q3 2017$6,304,000
+19.9%
6,475,000
+12.6%
0.78%
+14.0%
Q2 2017$5,256,000
+46.0%
5,750,000
+51.7%
0.68%
+28.0%
Q1 2017$3,599,000
+69.8%
3,790,000
+51.6%
0.54%
+73.1%
Q1 2015$2,119,000
+9.6%
2,500,0000.0%0.31%0.0%
Q4 2014$1,934,0002,500,0000.31%
Other shareholders
THERAVANCE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Wellesley Asset Management 41,771$44,921,0002.37%
LINDEN ADVISORS LP 45,495,000$48,853,0001.16%
BASSO CAPITAL MANAGEMENT, L.P. 4,759,000$5,092,0000.94%
SSI INVESTMENT MANAGEMENT LLC 6,850,000$7,332,0000.60%
TEALWOOD ASSET MANAGEMENT INC 1,390,000$1,492,0000.59%
Castle Creek Arbitrage, LLC 6,070,000$6,516,0000.48%
OAKTREE CAPITAL MANAGEMENT LP 21,717,000$23,355,0000.37%
AQR Arbitrage LLC 27,018,000$29,055,0000.34%
CSS LLC/IL 5,000,000$5,360,0000.27%
CQS Cayman LP 4,150,000$4,469,0000.21%
View complete list of THERAVANCE INC shareholders